1. Aim/Purpose of this Guideline
Aim/Purpose of this Guideline 1.1. The objective of this guideline is to provide health care professionals with clear and simple recommendations for the diagnosis and treatment of iron deficiency and anaemia in pregnancy and the postpartum period. 1.2. This guideline also contains recommendations for the initial management of women who present with low platelets in the antenatal period (NEW 2025). Refer to section 2.12. 1.3. This guideline makes recommendations for women and people who are pregnant. For simplicity of language the guideline uses the term women throughout, but this should be taken to also include people who do not identify as women but who are pregnant, in labour and in the postnatal period. When discussing with a person who does not identify as a woman, please ask them their preferred pronouns, and then ensure this is clearly documented in their notes to inform all health care professionals.
1.4. This version supersedes any previous versions of this document.
Data Protection Act 2018 (UK General Data Protection Regulation – GDPR) Legislation.
Legislation.
The Trust has a duty under the Data Protection Act 2018 and UK General Data Protection Regulations 2016/679 to ensure that there is a valid legal basis to process personal and sensitive data. The legal basis for processing must be identified and documented before the processing begins. In many cases we may need consent; this must be explicit, informed, and documented. We cannot rely on opt out, it must be opt in.
Data Protection Act 2018 and UK General Data Protection Regulations 2016/679 is applicable to all staff; this includes those working as contractors and providers of services.
For more information about your obligations under the Data Protection Act 2018 and UK General Data Protection Regulations 2016/679 please see the Information Use Framework Policy or contact the Information Governance Team.
Royal Cornwall Hospital Trust rch-tr.infogov@nhs.net
2. The Guidance
2.1. Introduction
2.1.1. Anaemia is common in pregnancy and is associated with adverse maternal and perinatal outcomes (Pavord et al 2019). It is possible to identify and treat it prior to childbirth.
2.1.2. Iron deficiency: in the UK, over 90% of women who are anaemic in pregnancy have iron deficiency anaemia (IDA). IDA remains a significant problem in the developed world: an estimated 30-40% of pregnant women have iron depletion (WHO 2008), as iron stores are often insufficient to meet the increasing demands of pregnancy.
Anaemia and iron deficiency: Diagnosis and Treatment throughout Pregnancy, Labour and Postpartum Period Clinical Guideline V4.3